Skip to main content
. Author manuscript; available in PMC: 2010 Dec 1.
Published in final edited form as: Int J Pharm. 2009 Aug 5;382(1-2):222–233. doi: 10.1016/j.ijpharm.2009.07.030

Fig. 3.

Fig. 3

Clearance of liver-targeting liposomes from plasma. Each BALB/c mouse was injected via the tail vein with a solution containing either 400 nmol liver-targeting liposomes, or 400 nmol control liposomes in which the liver-targeting peptide was omitted from the formulation. Blood samples were collected at 10 min and 1 h, and the quantity of liposomal lipid in the plasma determined by measurement of Bodipy-FL fluorescence, as described in the Materials and Methods. Values are nmol of liposomal lipid per mL plasma. Error bars are s.e.m, n=4.